All Pharma articles – Page 11
-
NewsExclusive: Trusts alerted as firm stockpiles clinical waste and body parts
Hundreds of tonnes of human body parts and dangerous waste from NHS patients has been stockpiled by a leading disposal company, sparking a major national incident.
-
NewsExclusive: No-deal Brexit 'will force up price of generic drugs'
The price of generic drugs could be forced up in the case of a no-deal Brexit, HSJ understands from senior industry sources.
-
NewsNHS wins landmark legal battle against drug companies
The NHS has today won a landmark legal battle against two international pharmaceutical giants which could save the health service hundreds of millions of pounds a year.
-
News712 unnecessary deaths – and how to avoid them: HSJ and BD roundtable
An HSJ roundtable, sponsored by BD, looked at how to reduce medication errors, improving outcomes for patients and reducing waste from unused or unnecessary medicines.
-
NewsPharma says government must act quickly to safeguard generic drugs supply
Pharmaceutical industry leaders have warned the government needs to be “fleet of foot” to avoid a significant cost if a no-deal Brexit disrupts approval of generic and biosimilar medicines.
-
Expert BriefingThe Integrator: How quickly is general practice reforming?
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ primary care and community services correspondent Rebecca Thomas.
-
NewsNHS told not to stockpile medication ahead of a 'no-deal' Brexit
NHS organisations should not spend money on “unnecessary” local stockpiling of medicine ahead of a possible no-deal Brexit.
-
CommentRunning to stand still
In light of the extra £20.5bn NHS funding, Anita Charlesworth outlines the various cost pressures that will likely consume most of the extra funding before improvements in quality and access can materialise
-
Expert BriefingThe Integrator: "Loaded gun" medicine plans may richochet back onto government
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ commissioning correspondent Sharon Brennan
-
NewsMinisters to ask drug companies to stockpile six weeks of medication
Drug companies are due to be asked to stockpile up to six weeks of medications ahead of a potential no deal Brexit, HSJ understands.
-
NewsBrexit stockpiling will face 'serious issues' and huge costs
s 3There are likely to be “serious issues” with the government’s plan to stockpile drugs and medical devices in case of a no-deal Brexit, according to senior figures in the pharmaceutical industry.
-
HSJ PartnersCollaboration is key to improving patient outcomes
Simon Grime explores opportunities for the NHS to work in partnership with industry online
-
NewsHancock to target NHS’s ‘very, very old school management’ culture
Matt Hancock accused the health service of showing a lack of respect for staff and having “very, very old school management which make it far less pleasant than it should be to work in the NHS”.
-
NewsGovernment plans to stockpile drugs in preparation for no-deal Brexit
The government is planning to stockpile drugs for a no-deal Brexit, the health secretary has announced.
-
Expert BriefingThe Integrator: Expensive drug dilemmas need a sophisticated approach
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ commissioning correspondent Sharon Brennan.
-
LeaderPragmatic Stevens focusses on keeping his vision alive
Simon Stevens is a man on a mission – and that mission is to control expectations.
-
HSJ AwardsHSJ Patient Safety Awards 2018: Improving Safety in Medicines Management
Winner Cumbria Partnership Foundation Trust: Clozapine clinic patient safety improvement initiative
-
NewsNHS to 'rapidly expand' treatment restrictions
NHS England plans to “rapidly expand” the number of medications and treatments it will restrict access to – beyond those which have already been announced or formally proposed.
-
NewsLord Darzi appointed chair of new innovation panel
Former health minister Lord Darzi has been appointed chair of a new innovation panel which will choose which “transformative” medical products should be fast tracked into the NHS.
-
HSJ InteractiveWhat benefits can biosimilars bring to the NHS?
Alison Moore reports on an HSJ roundtable which explored how the biosimilars market can be expanded, what the potential benefits and challenges are, and what needs to be done to increase uptake